CD8A and head and neck cancer: In agreement with the studies presented here, we have recently reported that in vivo administration of αPD-1 blockade followed by surgical resection increases Ca2+ fluxing abilities of CD8+ T cells by increasing the KCa3.1 and Kv1.3 channel function in head and neck cancer patients (Newton et al., 2020).